State Legislatures Reshape Public Health Legal Authority
Learn how state and territorial legislatures can bolster or restrict public health legal authority, with examples from early COVID-19 as well as 2024.
Learn how state and territorial legislatures can bolster or restrict public health legal authority, with examples from early COVID-19 as well as 2024.
One in three individuals who contract COVID-19 will experience lasting mental health impacts, according to a recent study. This startling discovery underscores the reality facing our nation: the challenges of this last year—the public ...
Continuing ASTHO’s Legislative Prospectus series—which highlights the top 10 public health policy issues for 2022—this post focuses on mental and behavioral health, as well as supporting the public health workforce.
People exposed to adverse childhood experiences are at risk for negative physical and/or mental health outcomes, substance use disorders, and unfavorable social outcomes in adulthood. One known risk factor for ACEs is caregiver stress, ...
In an effort to help meet demand, some states and territories have joined interjurisdictional licensing compacts that allow a mental healthcare provider licensed in one state to provide care in another state—without needing to gain ...
Recent state laws and governor emergency orders prohibiting universal school mask protocols are complicating the implementation of CDC’s evidence-based guidance for COVID-19 mitigation measures for in-person school. Ten states have enacted ...
Recent legislation at both the state and federal levels has significantly affected the ability of healthcare providers to serve patients virtually and across state lines.
States and municipalities are adopting tobacco retailer licensing (TRL) policies to control tobacco prevalence and impact. Learn more about TRL programs.
How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...